Nguy cơ viêm nội nhãn do nấm liên quan đến phẫu thuật đục thủy tinh thể: Một tổng quan ngắn

Mycopathologia et mycologia applicata - Tập 180 - Trang 291-297 - 2015
Tonya C. Smith1, Russell J. Benefield1, Jong Hun Kim2,3
1Department of Pharmacy, University of Utah Health Sciences Center, Salt Lake City, USA
2Division of Infectious Diseases, Department of Internal Medicine, University of Utah, Salt Lake City, USA
3Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seongbuk-gu, Republic of Korea

Tóm tắt

Viêm nội nhãn do nấm là một biến chứng hiếm gặp sau phẫu thuật đục thủy tinh thể và gây ra tỷ lệ bệnh tật đáng kể, bao gồm mất thị lực. Các tác nhân nấm gây bệnh thường gặp liên quan đến viêm nội nhãn do nấm sau phẫu thuật đục thủy tinh thể bao gồm các loài Candida và các nấm mốc như loài Aspergillus và Fusarium. Chẩn đoán sớm và điều trị kháng nấm hiệu quả sau khi có nghi ngờ lâm sàng cao là cần thiết để giảm thiểu các biến chứng không mong muốn và bảo tồn chức năng mắt. Bài tổng quan này bàn luận về dịch tễ học, sinh bệnh học, các đặc điểm lâm sàng, chẩn đoán, quản lý và kết quả liên quan đến viêm nội nhãn do nấm sau phẫu thuật đục thủy tinh thể.

Từ khóa

#viêm nội nhãn do nấm #phẫu thuật đục thủy tinh thể #Candida #Aspergillus #Fusarium #chẩn đoán #điều trị

Tài liệu tham khảo

Mamalis N. Endophthalmitis. J Cataract Refract Surg. 2002;28(5):729–30. Chhablani J. Fungal endophthalmitis. Expert Rev Anti Infect Ther. 2011;9(12):1191–201. Taban M, Behrens A, Newcomb RL, Nobe MY, Saedi G, Sweet PM, McDonnell PJ. Acute endophthalmitis following cataract surgery: a systematic review of the literature. Arch Ophthalmol. 2005;123(5):613–20. West ES, Behrens A, McDonnell PJ, Tielsch JM, Schein OD. The incidence of endophthalmitis after cataract surgery among the US. Medicare population increased between 1994 and 2001. Ophthalmology. 2005;112(8):1388–94. Narang S, Gupta A, Gupta V, Dogra MR, Ram J, Pandav SS, Chakrabarti A. Fungal endophthalmitis following cataract surgery: clinical presentation, microbiological spectrum, and outcome. Am J Ophthalmol. 2001;132(5):609–17. Wykoff CC, Flynn HW Jr, Miller D, Scott IU, Alfonso EC. Exogenous fungal endophthalmitis: microbiology and clinical outcomes. Ophthalmology. 2008;115(9):1501–7. Gollogly HE, Hodge DO, St Sauver JL. Increasing incidence of cataract surgery: population-based study. J Cataract Refract Surg. 2013;39(9):1383–9. Keynan Y, Finkelman Y, Lagacé-Wiens P. The microbiology of endophthalmitis: global trends and a local perspective. Eur J Clin Microbiol Infect Dis. 2012;31(11):2879–86. Lemley CA, Han DP. Endophthalmitis: a review of current evaluation and management. Retina. 2007;27(6):662–80. Cao H, Zhang L, Li L, Lo S. Risk factors for acute endophthalmitis following cataract surgery: a systematic review and meta-analysis. PLoS One. 2013;8(8):e71731. Du DT, Wagoner A, Barone SB, Zinderman CE, Kelman JA, Macurdy TE, Forshee RA, Worrall CM, Izurieta HS. Incidence of endophthalmitis after corneal transplant or cataract surgery in a medicare population. Ophthalmology. 2014;121(1):290–8. Gower EW, Keay LJ, Stare DE, Arora P, Cassard SD, Behrens A, Tielsch JM, Schein OD. Characteristics of endophthalmitis after cataract surgery in the United States medicare population. Ophthalmology. 2015. pii: S0161-6420(15)00419-4. doi:10.1016/j.ophtha.2015.04.036. [Epub ahead of print]. Anand AR, Therese KL, Madhavan HN. Spectrum of aetiological agents of postoperative endophthalmitis and antibiotic susceptibility of bacterial isolates. Indian J Ophthalmol. 2000;48(2):123–8. Sheng Y, Sun W, Gu Y, Lou J, Liu W. Endophthalmitis after cataract surgery in China, 1995–2009. J Cataract Refract Surg. 2011;37(9):1715–22. Buchta V, Feuermannová A, Váša M, Bašková L, Kutová R, Kubátová A, Vejsová M. Outbreak of fungal endophthalmitis due to Fusarium oxysporum following cataract surgery. Mycopathologia. 2014;177(1–2):115–21. Güngel H, Eren MH, Pınarcı EY, Altan C, Baylançiçek DO, Kara N, Gürsel T, Yegenoğlu Y, Susever S. An outbreak of Fusarium solani endophthalmitis after cataract surgery in an eye training and research hospital in Istanbul. Mycoses. 2011;54(6):e767–74. Vilela RC, Vilela L, Vilela P, Vilela R, Motta R, Pôssa AP, de Almeida C, Mendoza L. Etiological agents of fungal endophthalmitis: diagnosis and management. Int Ophthalmol. 2014;34(3):707–21. McCray E, Rampell N, Solomon SL, Bond WW, Martone WJ, O’Day D. Outbreak of Candida parapsilosis endophthalmitis after cataract extraction and intraocular lens implantation. J Clin Microbiol. 1986;24(4):625–8. Pulido JS, Folberg R, Carter KD, Coonan P. Histoplasma capsulatum endophthalmitis after cataract extraction. Ophthalmology. 1990;97(2):217–20. Downie HA. Post-cataract cryptococcal endophthalmitis. Aust N Z J Ophthalmol. 1992;20(3):272–3. Rychener RO. Intra-ocular mycosis. Trans Am Ophthalmol Soc. 1933;31:477–96. Silva RA, Sridhar J, Miller D, Wykoff CC, Flynn HW Jr. Exogenous fungal endophthalmitis: an analysis of isolates and susceptibilities to antifungal agents over a 20-year period (1990–2010). Am J Ophthalmol. 2015;159(2):257–64. Durand ML. Endophthalmitis. Clin Microbiol Infect. 2013;19(3):227–34. Ando N, Takatori K. Fungal flora of the conjunctival sac. Am J Ophthalmol. 1982;94(1):67–74. Liotet S, Krzywkowski JC, Warnet VN, Jacq C. Conjunctival fungal flora of healthy people. J Fr Ophtalmol. 1980;3(10):557–60. Menezes EA, Trindade EC, Costa MM, Freire CC, Cavalcante Mde S, Cunha FA. Airborne fungi isolated from Fortaleza city, State of Ceará, Brazil. Rev Inst Med Trop Sao Paulo. 2004;46(3):133–7. Kunimoto DY, Das T, Sharma S, Jalali S, Majji AB, Gopinathan U, Athmanathan S, Rao TN. Microbiologic spectrum and susceptibility of isolates: part II. Posttraumatic endophthalmitis. Endophthalmitis Research Group. Am J Ophthalmol. 1999;128(2):242–4. Kunimoto DY, Das T, Sharma S, Jalali S, Majji AB, Gopinathan U, Athmanathan S, Rao TN. Microbiologic spectrum and susceptibility of isolates: part I. Postoperative endophthalmitis. Endophthalmitis Research Group. Am J Ophthalmol. 1999;128(2):240–2. Akçakaya AA, Sargin F, Erbil HH, Yazici S, Yaylali SA, Mesçi C, Ergin S, Midilli K. A cluster of acute-onset postoperative endophthalmitis over a 1-month period: investigation of an outbreak caused by uncommon species. Br J Ophthalmol. 2011;95(4):481–4. Forster RK, Abbott RL, Gelender H. Management of infectious endophthalmitis. Ophthalmology. 1980;87(4):313–9. Driebe WT Jr, Mandelbaum S, Forster RK, Schwartz LK, Culbertson WW. Pseudophakic endophthalmitis. Diagnosis and management. Ophthalmology. 1986;93(4):442–8. Fine BS, Zimmerman LE. Exogenous intraocular fungus infections with particular reference to complications of intraocular surgery. Am J Ophthalmol. 1959;48(2):151–65. Theodore FH. Etiology and diagnosis of fungal postoperative endophthalmitis. Ophthalmology. 1978;85(4):327–40. Sunaric-Mégevand G, Pournaras CJ. Current approach to postoperative endophthalmitis. Br J Ophthalmol. 1997;81(11):1006–15. Bennett JE, Dolin R, Mandell Blaser MJ. Douglas, and Bennett’s principles and practice of infectious diseases. 8th ed. Amsterdam: Elsevier; 2014. Vaziri K, Schwartz SG, Kishor K, Flynn HW Jr. Endophthalmitis: state of the art. Clin Ophthalmol. 2015;9:95–108. Pappas PG, Kauffman CA, Andes D, Benjamin DK Jr, Calandra TF, Edwards JE Jr, Filler SG, Fisher JF, Kullberg BJ, Ostrosky-Zeichner L, Reboli AC, Rex JH, Walsh TJ, Sobel JD. Infectious Diseases Society of America. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;48(5):503–35. Koç A, Onal S, Yenice O, Kazokoglu H. Pars plana vitrectomy and intravitreal liposomal Amphotericin B in the treatment of Candida endophthalmitis. Ophthalmic Surg Lasers Imaging. 2010;9:1–3. Riddell J 4th, Comer GM, Kauffman CA. Treatment of endogenous fungal endophthalmitis: focus on new antifungal agents. Clin Infect Dis. 2011;52(5):648–53. Lass-Flörl C. Triazole antifungal agents in invasive fungal infections: a comparative review. Drugs. 2011;71(18):2405–19. Hariprasad SM, Mieler WF, Holz ER, Gao H, Kim JE, Chi J, Prince RA. Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans. Arch Ophthalmol. 2004;122(1):42–7. Gao H, Pennesi ME, Shah K, Qiao X, Hariprasad SM, Mieler WF, Wu SM, Holz ER. Intravitreal voriconazole: an electroretinographic and histopathologic study. Arch Ophthalmol. 2004;122(11):1687–92. Tu EY, McCartney DL, Beatty RF, Springer KL, Levy J, Edward D. Successful treatment of resistant ocular fusariosis with posaconazole. Am J Ophthalmol. 2007;143(2):222–7. Pettit NN, Carver PL. Isavuconazole: a new option for the management of invasive fungal infections. Ann Pharmacother. 2015;49(7):825–42. Sarria JC, Bradley JC, Habash R, Mitchell KT, Kimbrough RC, Vidal AM. Candida glabrata endophthalmitis treated successfully with caspofungin. Clin Infect Dis. 2005;40(5):e46–8. Gauthier GM, Nork TM, Prince R, Andes D. Subtherapeutic ocular penetration of caspofungin and associated treatment failure in Candida albicans endophthalmitis. Clin Infect Dis. 2005;41(3):e27–8.